Faculty Collaboration Database

Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine and Head and Neck Disease Site Working Group, Part 2 of 2: Perioperative Management and Outcomes of Pheochromocytoma and Paraganglioma. Ann Surg Oncol 2020 May;27(5):1338-1347

Date

03/01/2020

Pubmed ID

32112213

Pubmed Central ID

PMC8638680

DOI

10.1245/s10434-020-08221-2

Scopus ID

2-s2.0-85081382857 (requires institutional sign-in at Scopus site)   24 Citations

Abstract

This is the second part of a two-part review on pheochromocytoma and paragangliomas (PPGLs). In this part, perioperative management, including preoperative preparation, intraoperative, and postoperative interventions are reviewed. Current data on outcomes following resection are presented, including outcomes after cortical-sparing adrenalectomy for bilateral adrenal disease. In addition, pathological features of malignancy, surveillance considerations, and the management of advanced disease are also discussed.

Author List

Patel D, Phay JE, Yen TWF, Dickson PV, Wang TS, Garcia R, Yang AD, Kim LT, Solórzano CC

Authors

Tracy S. Wang MD, MPH Professor in the Surgery department at Medical College of Wisconsin
Tina W F Yen MD, MS Professor in the Surgery department at Medical College of Wisconsin

MESH terms used to index this publication - Major topics in bold

Adrenal Gland Neoplasms
Adrenalectomy
Adrenergic alpha-Antagonists
Adrenergic beta-Antagonists
Calcium Channel Blockers
Enzyme Inhibitors
Fluid Therapy
Humans
Hyperinsulinism
Hypertension
Hypoglycemia
Hypotension
Laparoscopy
Multiple Endocrine Neoplasia Type 2a
Multiple Endocrine Neoplasia Type 2b
Neoplasm Recurrence, Local
Paraganglioma
Paraganglioma, Extra-Adrenal
Perioperative Care
Pheochromocytoma
Postoperative Complications
Robotic Surgical Procedures
Treatment Outcome
Tyrosine 3-Monooxygenase
Vasoconstrictor Agents
von Hippel-Lindau Disease